Clinical Trials Browser

Terminated × Melanoma × Imatinib Mesylate × Clear all

NCT00421317 2026-03-13

O-Mel-Inib

Phase 2 Terminated

Melanoma

NCT00667953 2023-03-30

Study of Temzolomide and Gleevec in Advanced Melanoma

Phase 1/2 Terminated

32 enrolled 8 charts

Melanoma

NCT00402662 2013-12-18

A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

Phase 2 Terminated

Melanoma